Pharmaceutical Export Training

by | Apr 19, 2022 | Blog, Export Training, Training

Export Training for the pharmaceutical industry is a highly regulated sector where the paramount focus is on minimising the risk to patient safety has led to significant changes in recent years.

Our one-day Export Training provides an overview of the rules and regulations to ensure compliance when handling and distributing medicinal products in the UK for the Export market.

The course will also provide an insight into the competent authority and its role in ensuring patient safety outside the EEA.

Who should attend the new PCL Export course?

The course would be beneficial for any personnel involved in the export pharmaceutical distribution model looking to obtain a more in-depth understanding of the export and the regulations a Wholesale Distributor of medicinal products must adhere to.

If you already Export Medicines or are intending to Export medicines, then you should attend the new PCL Export course. You will learn more about the quality aspects and processes required to Export medicines from the UK outside the EEA.

During the course, we will cover, but will not be limited to the key subject areas listed below.

  • What is Export?
  • EEA members
  • Risk Assessments
  • Possible Delays
  • Bona Fides
  • HMRC Requirements
  • Documentation, including HAWB & MAWB details, Commercial Invoices
  • Transportation, including sea freight, air freight, air courier and road freight
  • Packaging
  • Customs & Local Government Authorities at Destination 

Upcoming Course dates

  • 11th May 2022
  • 15th June 2022
  • 13th July 2022
  • 10th August 2022
  • 14th September 2022
  • 12th October 2022
  • 9th November 2022
  • 14th December 2022

To see all our upcoming courses please go to our training calendar or to book one of our upcoming courses please visit our bookings page.

Testimonials

Very informative, Jackie created a relaxed atmosphere which was conducive to active participation of the whole group. Jackie also provided a summary of the recent MHRA convention which was very beneficial.
Testimonial from David Burns